https://www.avient.com/news/polyone-corporation-host-investor-day
January 8, 2015
While we remain laser focused and in aggressive pursuit of our 2015 performance targets, we’re also planning for a future driven by specialty innovation, collaboration and growth, leading to strong double digit adjusted EPS expansion for many years to come.
https://www.avient.com/sites/default/files/2021-12/avient-sarl-czech-republic-branch-register-extract-dec-3-2021.pdf
Czech Republic Branch
Údaje platné ke dni: 3. prosince 2021 03:45 1/1
Výpis
z obchodního rejstříku, vedeného
Městským soudem v Praze
oddíl , vložka A 78870
Datum vzniku a zápisu: 30. srpna 2018
Spisová značka: A 78870 vedená u Městského soudu v Praze
Označení odštěpného
závodu:
Avient S.à r.l., Czech Republic Branch
Sídlo: Pobřežní 620/3, Karlín, 186 00 Praha 8
Identifikační číslo: 074 10 026
Právní forma: Odštěpný závod zahraniční právnické osoby
Předmět podnikání:
Výroba, obchod a služby neuvedené v přílohách 1 až 3 živnostenského zákona
Vedoucí odštěpného závodu:
LÁSZLÓ MEDNYÁNSZKY, dat. nar. 23. listopadu 1967
9400 Sopron, Ösvény 7, Maďarská republika
Zřizovatel - zahraniční osoba:
Avient S.à r.l.
9638 Pommerloch, Route de Bastogne 19, Lucemburské velkovévodství
Registrační číslo: B226205
Právní forma: společnost s ručením omezeným
Statutární orgán zřizovatele - zahraniční osoby:
HOLGER HANS KRONIMUS, dat. nar. 26. ledna 1968
76571 Gaggenau, Adolf Dambach-Strasse 2, Spolková republika Německo
Den vzniku funkce: 4. července 2018
Den vzniku členství: 4. července 2018
CHRISTOPH PALM, dat. nar. 16. května 1963
9638 Pommerloch, Route de Bastogne 19, Lucemburské velkovévodství
Den vzniku funkce: 4. července 2018
Den vzniku členství: 4. července 2018
ZANETA GABRIELA POTOCZNY, dat. nar. 17. října 1974
9638 Pommerloch, route de Bastogne 19, Lucemburské velkovévodství
Den vzniku funkce: 27. února 2019
Den vzniku členství: 27. února 2019
NORBERT MERKLEIN, dat. nar. 3. května 1964
4132 Muttenz, Rothausstrasse 61, Švýcarská konfederace
Den vzniku funkce: 18. ledna 2021
Den vzniku členství: 18. ledna 2021
Počet členů: 4
Společnost je platně vázána nebo zastupována vůči třetím osobám takto: má-li
Společnost více než jednoho jednatele, pak podpisem kteréhokoli jednatele.
https://www.avient.com/company/purpose-strategic-framework
Our strategy is enabled by our focus on four Strategic Drivers: portfolio prioritization, amplify innovation, digital for operational excellence and growth, and leadership, talent and culture for the Avient of the future.
https://www.avient.com/investor-center/investor-news/archives?page=10
Avient Expects Double Digit Sales Growth in 5G Applications
https://www.avient.com/sites/default/files/2022-11/AVNT Q3 2022 Earnings Presentation - Website Final.pdf
OPS)
16
Sales Adjusted EBITDA
$818 $823
+ 1%
Adjusted EPS
+ 8% - 3%
(in millions) (in millions)
(+ 9% excluding FX) (+ 18% excluding FX) (+ 5% excluding FX)
Q3 EBITDA BRIDGE
(PRO FORMA TOTAL COMPANY)
17
Price increases more than
offset raw material and
supply chain impacts
$ millions
CAI:
Price / Mix 68
Inflation (44)
SEM:
Price / Mix 41
Inflation (26)
Net Price Benefit 39
Wage and Energy Inflation (14)
Clariant Color Integration Synergies 6
Incentives, Other Employee Costs 14
FX (11)
Q3 2022 $137
Adjusted
Q3 2021 $ 142
Demand (39)
Q3 2022 SEGMENT PERFORMANCE
18
CAI
$587
$566
Sales
$93 $93
SEM Pro Forma
$326 $319
Sales
$70
$62
(+ 4% excluding FX)
- 4% - 2%
(+ 5% excluding FX)
Flat
(+ 7% excluding FX)
- 11%
(- 7% excluding FX)
$500
$585
$2.60
$2.95
FULL YEAR 2022 GUIDANCE
19
Sales Adjusted EBITDA
$3,375
$3,635
Adjusted EPS
(in millions) (in millions)
20
SUMMARY
• Executed the plans we laid out earlier this year
• Completed the Dyneema acquisition and Distribution divestiture
amid challenging market conditions
• Paid down debt and expect to finish the year modestly levered at
3.1x net debt to 2022 pro forma adjusted EBITDA
• Expect $200 million of free cash flow in 2022
• Entering an economic slowdown with a portfolio that is better
positioned than ever before
• Updated our EPS guidance to $2.60 from continuing operations
SEGMENT DATA
U.S. & Canada
Latin America
2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
21%
Building and
END MARKET REVENUE
(1) Total company adjusted EBITDA of $585M includes corporate costs.
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$585M$3,635M
23
C O L O R , A D D I T I V E S & I N K S
2022 REVENUE | $2 .3 B ILL ION
US & Canada
Latin America
END MARKET REGION
24
33%
Building &
1% Energy
Figures represent 2022 full year estimates
S P E C I A LT Y E N G I N E E R E D M AT E R I A L S
2022 PRO FORMA REVENUE | $1 .3 B ILL ION
END MARKET
US & Canada
50%
REGION
25 Figures represent 2022 full year estimates
19%
8%Industrial
16%
Building &
31%
28%
13%
Building &
3%
2% Defense
(20% of sales)
2022 PROFORMA AVIENT REGIONAL SALES
BY END MARKET
29%
13%
17%
Building &
(35% of sales)
14%
Building &
12%
US &
Canada
(40% of sales)
49%
Building &
LATAM
(5% of sales)
3%Telecommunications
Figures represent 2022 full year estimates
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
The Q3 2022 "Pro Forma
APM" adjustments reflect periods prior to the acquisition date and are preliminary estimates for APM’s results for the months of July and August.
3
AVNT Q3 2022 Earnings Presentation - Website v2.pdf
AVNT Q3 2022 Earnings Presentation - Website Update.pdf
AVNT Q3 2022 Earnings Presentation - Website.pdf
11.7 823am IR Deck - AVNT-2022.09.30 (002).pdf
https://www.avient.com/products/thermoplastic-elastomers/versollan-thermoplastic-elastomers
Guide to part design, mold design, hot runner systems, overmolding, machine selection, material handling and preparation, processing conditions and troubleshooting for GLS™ solutions
Guide to overmolding material selection, part and mold design, material handling and preparation, TPE injection molding, processing, maximizing adhesion and troubleshooting for GLS™ TPEs
https://www.avient.com/products/engineered-polymer-formulations/sustainable-formulations/gravi-tech-lead-replacement-formulations
Injection molding parameters and troubleshooting recommendations for Gravi-Tech™
Injection molding parameters and troubleshooting recommendations for Gravi-Tech™ (Chinese language version)
https://www.avient.com/sites/default/files/resources/Wells%2520Fargo%2520Conference%2520-%2520IR%2520Presentation%25205-6-2015%2520-%2520wNon%2520GAAP%2520and%2520Appendix.pdf
You are
advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and
Exchange Commission.
PolyOne Corporation Page 3
Use of Non-GAAP Measures
This presentation includes the use of both GAAP (generally accepted accounting
principles) and non-GAAP financial measures in certain cases throughout this
presentation.
S&P 500
PolyOne Corporation Page 9
2006 Q1 2015 2015 Target
“Where we were” “Where we are” (Est. in 2012)
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 16.2% 12 – 16%
Global Specialty Engineered
Materials 1.1% 16.3% 12 – 16%
Designed Structures & Solutions 1.4% (2012) 2.7% 8 – 10%
Performance Products &
Solutions 5.5% 6.5% 9 – 12%
Distribution 2.6% 5.9% 6 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 69% 65 – 75%
3) ROIC 5.0% 11.4% 15%
4) Adjusted EPS Growth N/A 5% Double Digit
Expansion
Proof of Performance & 2015 Goals
PolyOne Corporation Page 10
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2014
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
27%
2006 2014
Specialty Platform
Gross Margin %
20%
44%
2006 2014
Specialty Vitality Index Target ≥ 35%
PolyOne Corporation Page 11
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 12
Prototype Frame
Opportunity
Scale-up &
Test Market
Build
Business Case
Commercial
Launch
Phase
1
Phase
2
Phase
3
Phase
4
Phase
5
4
11
5
10
6
9
3 4 2
15
9
1
10
4
Breakthrough
Platform
Derivative
A Rich Pipeline of Opportunity
Number of Projects 25 14 19 17 18 93
Addressable Market
($ millions) $800 $450 $450 $1,700
PolyOne Corporation Page 13
60%
98%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 Q1 2015
Pension Funding**
As of March 31, 2015
Debt Maturities & Pension Funding – 3/31/15
Net Debt / EBITDA* = 2.1x
$49
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of March 31, 2015
($ millions)
Coupon Rate: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 3/31/2015
PolyOne Corporation Page 14
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales,
marketing, and
technical capabilities
Investing in operational
and LSS initiatives
~75% of capital
expenditures fund
growth initiatives Organic
Growth
Acquisitions
Share
Repurchases
Dividends
$0.16
$0.20 $0.24
$0.32
$0.40
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015
Annual Dividend
Targets that expand
our:
• Specialty offerings
• End market
presence
• Geographic breadth
Synergy opportunities
Adjacent material
solutions
Repurchased over
500k shares in Q1
2015
Repurchased 11.8
million shares since
early 2013
8.2 million shares are
available for
repurchase under the
current authorization
PolyOne Corporation Page 15
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 16
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520–%2520Goldman%2520Sachs%2520Conference%25202015.pdf
You are
advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and
Exchange Commission.
PolyOne Corporation Page 3
Use of Non-GAAP Measures
This presentation includes the use of both GAAP (generally accepted accounting
principles) and non-GAAP financial measures.
S&P 500
PolyOne Corporation Page 9
2006 Q1 2015 2020
“Where we were” “Where we are” Platinum Vision
1) Operating Income %
Specialty:
Global Color, Additives & Inks 1.7% 16.2% 20%+
Global Specialty Engineered
Materials 1.1% 16.3% 20%+
Designed Structures & Solutions 1.4% (2012) 2.7% 12 – 14%
Performance Products &
Solutions 5.5% 6.5% 10 – 12%
Distribution 2.6% 5.9% 6.5 – 7.5%
2) Specialty Platform % of
Operating Income 6.0% 69% 80%+
3) ROIC 5.0% 11.4% 15%
4) Adjusted EPS Growth N/A
22 Consecutive
Quarters of
EPS Growth
Double Digit
Expansion
Proof of Performance & 2020 Goals
PolyOne Corporation Page 10
Platinum Vision: Pathway to Accelerated Growth
Organic
Sales Growth
Margin
Expansion
Share
Repurchases
Acquisitions
PolyOne Corporation Page 11
Innovation Drives Earnings Growth
*Percentage of Specialty Platform revenue from products introduced in last five years
$20
$53
2006 2014
Research & Development
Spending
($ millions)
Specialty Platform
Vitality Index Progression*
14%
27%
2006 2014
Specialty Platform
Gross Margin %
20%
44%
2006 2014
Specialty Vitality Index Target ≥ 35%
PolyOne Corporation Page 12
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 13
Prototype Frame
Opportunity
Scale-up &
Test Market
Build
Business Case
Commercial
Launch
Phase
1
Phase
2
Phase
3
Phase
4
Phase
5
6
9
7
3
5
12
5 3 2
8
4
2
4
3
1
Breakthrough
Platform
Derivative
A Rich Pipeline of Opportunity
Number of Projects 14 8 18 12 22 74
Addressable Market
($ millions) $700 $600 $600 $1,900
PolyOne Corporation Page 14
60%
98%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2008 Q1 2015
Pension Funding**
As of March 31, 2015
Debt Maturities & Pension Funding
Net Debt / EBITDA* = 2.1x
$49
$317
$600
$0
$100
$200
$300
$400
$500
$600
$700
$800
2015 2020 2023
Debt Maturities
As of March 31, 2015
($ millions)
Coupon Rate: 7.500% 7.375% 5.250%
** includes US-qualified pension plans only *TTM 3/31/2015
PolyOne Corporation Page 15
Free Cash Flow and Strong Balance Sheet
Fund Investment / Shareholder Return
Expanding our sales,
marketing, and
technical capabilities
Investing in operational
and LSS initiatives
~75% of capital
expenditures fund
growth initiatives Organic
Growth
Acquisitions
Share
Repurchases
Dividends
$0.16
$0.20 $0.24
$0.32
$0.40
$0.10
$0.20
$0.30
$0.40
$0.50
2011 2012 2013 2014 2015
Annual Dividend
Targets that expand
our:
• Specialty offerings
• End market
presence
• Geographic breadth
Synergy opportunities
Adjacent material
solutions
Repurchased over
500k shares in Q1
2015
Repurchased 11.8
million shares since
early 2013
8.2 million shares are
available for
repurchase under the
current authorization
PolyOne Corporation Page 16
PolyOne Core Values
Innovation
Collaboration
Excellence
PolyOne Corporation Page 17
The New PolyOne: A Specialty Growth Company
Why Invest In PolyOne?
https://www.avient.com/news/polyone-announces-first-quarter-2015-results
Special items, after tax (Attachment 3)
Attachment 3
Tax benefit on special items (Attachment 3)